National Study Finds Further Evidence That Hospice Use Does 'Not

Total Page:16

File Type:pdf, Size:1020Kb

National Study Finds Further Evidence That Hospice Use Does 'Not Provided as an educational service by St Joseph Hospice Vol. 13, Issue 3 Nov/Dec/Jan 2011-2012 National Study Finds Further Evidence That Hospice Use Does ‘Not Compromise Survival’ Bolstering other recent findings that hospice care does not shorten — and may even prolong — survival among “Appropriate timing of referral to hospice gives terminally ill cancer patients with cancer, an international patients and their families more time and opportunity to benefit team of researchers reports that Medi- from palliative services and avoid futile interventions. Concern care hospice patients have a slight sur- vival advantage over their nonhospice about hastening death should not be a barrier to hospice care.” counterparts. Further, aggressive care — Saito et al, Journal of Palliative Medicine delivered late in the illness is more likely merely to shorten hospice stay than to extend life. have comparable or even longer sur- KEY FINDINGS: “Despite a significant relationship vival compared to nonhospice patients, • Survival was found to favor hospice between aggressive care at the end of based on three different statistical ap- patients relative to nonhospice pa- life and no or only short-term hospice proaches,” write the authors of a re- tients by 5.0% at one year follow- stay, hospice patients were found to port published in the Journal of Pal- ing diagnosis (25.7%, hospice pa- liative Medicine. tients vs 20.7%, nonhospice) and by The team conducted multiple analy- 1.4% at two years post-diagnosis Inside: ses of data on Medicare patients (n = (6.9% vs 5.5%). NewsLine .............................2-3 7879) who survived for at least three • Longer-term hospice patients had 3 Achieving Equitable Access to Quality months following diagnosis of non- longer survival than nonhospice Hospice and Palliative Care: We’re at small-cell lung cancer between 1991 the ‘Tipping Point,’ Declares Expert patients (hazard ratio [HR], 0.87; and 1999. Patients were divided into Research Monitor ...............4-6 95% confidence interval [CI], 0.83 matched “hospice” and “nonhospice” to 0.91; p = 0.0001). 3 When Patients Have Multiple groups, with the hospice group further Comorbidities: The Challenges of • Short-term hospice patients had a End-of-Life Discussions without divided according to length of stay: similar, although slight, survival ad- One Clear Terminal Diagnosis “short term” (< 3 days in hospice) or 3 vantage compared with patients in Timely Receipt of Hospice Services “longer term” (> 4 days in hospice). Yields Higher Family Perceptions the nonhospice group (HR, 0.94; of Quality of Nursing Home Death Indicators of “aggressive care” near among Dementia Patients 95% CI, 0.83 to 1.05; p = 0.26). the end of life included: a new chemo- 3 New Accreditation Standards from the • Hospice patients with short-term ad- American College of Surgeons Focus on therapy regimen begun less than 30 missions were more likely to be male, Patient-Centered, Supportive Approach days before death; receiving a last dose to Hospice and Palliative Care urban dwellers, and to have received 3 Informing Patients of Impending Death of chemotherapy within 14 days of aggressive care near the end of life. Linked to Improved End-of-Life Care, death; more than one emergency de- with No Increase in Pain or Anxiety partment visit or hospital admission in OVERALL: Clinician Resources ..............7 the last month of life; or being hospi- • 47.9% of all patients received hos- 3 Approach to Addressing Cultural talized for longer than 14 days in the Beliefs and Preferences pice care. final month. Continued on Page 3 NEWSLINE Achieving Equitable Access to Quality Hospice and Palliative Care: We’re at the ‘Tipping Point,’ Declares Expert Caring for the sickest Medicare beneficiaries — the 10% with serious illness or multiple chronic conditions — ac- Policy Focus for Improving Access counts for 57% of the total program spending, yet studies to Quality Palliative Care demonstrate that these patients and their families are re- ceiving health care of inadequate quality. The dual goals • Enhance the medical and nursing workforce with ex- of cutting expenditures and delivering the care that patients pertise in palliative care need and desire can be achieved by strengthening access • Invest in the field’s research evidence base to quality palliative care and hospice. • Increase availability of services in hospitals and nurs- That is according to an article published in the Septem- ing homes ber issue of The Milbank Quarterly, a peer-reviewed, — Meier, The Milbank Quarterly multidisciplinary journal of population health and health policy. The article reviews the benefits of palliative care and the barriers to its delivery, and suggests policy ap- clarity of the care plan, and consistent follow-through proaches for standardizing access to high-quality care. • Easing the burden experienced by families and in- “Palliative care and hospice services improve patient- creasing satisfaction by supporting families in routine centered outcomes such as pain, depression, and other care, in crisis, and in bereavement symptoms; patient and family satisfaction; and the re- COST SAVINGS OF PALLIATIVE CARE AND HOSPICE ceipt of care in the place that the patient chooses,” writes author Diane E. Meier, MD, professor of geriatrics and Recent data show that the average per-patient, per-ad- palliative medicine at the Mount Sinai School of Medi- mission, net cost saved by using hospital palliative care cine, New York City. consultation is $2659, which translates into an estimated “By helping patients get the care they need to avoid un- $1.2 billion saved per year by the programs currently es- necessary emergency department and hospital stays and tablished at more than 60% of U.S. hospitals. Meier points shifting the locus of care to the home or community, pallia- out that this figure could increase to $4 billion saved, if tive care and hospice reduce health care spending for appropriate hospital palliative care services were expanded America’s sickest and most costly patient populations.” to meet the needs of most patients who are currently dis- charged with serious and complex chronic illness without PALLIATIVE CARE AND HOSPICE TEAMS: benefit of these services. DELIVERING HIGH-QUALITY CARE Hospice care, currently provided to over 1.5 million pa- Much of the strength of palliative care services lies in tients yearly, has been shown to reduce total health care their coordinated, patient-centered, multidisciplinary ap- costs by an estimated $2300 per Medicare beneficiary, with proach. Palliative care and hospice teams improve quality an average annual savings of more than $3.5 billion per of care by: year. When patients disenroll from hospice, their medical • Identifying and rapidly treating distressing symptoms costs are nearly five times higher than for those who re- that are shown to increase medical complications and main in hospice care, Meier points out. hospitalization The United States is unique in its categorization of pal- • Planning for safe transitions from acute care to more sup- liative care into two distinct types, notes Meier, in that it portive settings, such as home health care, home or in- labels “palliative care” as needs-based, with no prognostic patient hospice, or nursing home care with hospice restriction, and “hospice” as palliative care that is restricted • Avoiding nonbeneficial or harmful tests, procedures, or to patients with a prognosis of living six months or less. specialty consultations The relatively new field of palliative care outside of hos- • Meeting often with patients and families to establish real- pice has been created largely by private sector contribu- istic goals, leading to better-informed decision making, Continued on Page 3 PAGE 2 QUALITY OF LIFE MATTERS NOV/DEC/JAN 2011-2012 NEWSLINE National Study Finds Further Evidence That Hospice Use Does ‘Not Compromise Survival’ Continued from Page 1 cancer patients nearing death, the authors point out. “Ad- vances in medical technologies and a perception that pa- • 92.6% of the hospice patients died under hospice care, tients favor receiving aggressive care even very near death while only 2.8% died in a hospital. for small expected benefits may reduce the number of pa- • In contrast, 39.7% of nonhospice patients died in an acute tients referred to hospice,” they suggest. care setting. Nevertheless, the authors state firmly in their conclusion, • Hospice patients were older, more likely to be non-His- “[the] use of hospice and length of hospice stay for Medi- panic white and female, and more likely to live in urban care patients with advanced non-small-cell lung cancer did areas with high hospice availability. not compromise survival.” “[R]egional availability of hospice was associated with Source: “Hospice Care and Survival among Elderly Patients with Lung any hospice use, but not with length of hospice stay,” the Cancer,” Journal of Palliative Medicine; August 2011; 14(8):929-939. Saito AM, Landrum MB, Neville BA, Ayanian JZ, Weeks JC, Earle CC; authors point out. “Instead, experiencing aggressive end- Laboratory of Clinical, Epidemiological, and Health Services Research, of-life care was more predictive of shorter duration of hos- Clinical Research Center, National Hospital Organization Nagoya pice use.” Medical Center, Aichi, Japan; Department of Health Care Policy, Harvard Medical School, Boston; Division of Population Sciences, Department of Despite the results of recent studies showing that hos- Medical Oncology, Dana-Farber Cancer Institute, Boston; Division of General Medicine, Brigham and Women’s Hospital, Boston; Cancer Care pice care does not hasten death, there is a current trend in Ontario, Ontario Institute for Cancer Research, and the Institute for this country toward increasingly aggressive care among Clinical Evaluative Sciences, Toronto. Achieving Equitable Access to Quality Hospice and Palliative Care: We’re at the ‘Tipping Point,’ Declares Expert Continued from Page 2 oped by the American Academy of Hospice and Pallia- tions and initiatives from major professional organizations.
Recommended publications
  • Research Training in the Biomedical, Behavioral and Clinical Sciences
    RESEARCH TRAINING IN THE BIOMEDICAL, BEHAVIORAL, AND CLINICAL RESEARCH SCIENCES Committee to Study the National Needs for Biomedical, Behavioral, and Clinical Research Personnel Board on Higher Education and Workforce Policy and Global Affairs THE NATIONAL ACADEMIES PRESS 500 Fifth Street, N.W. Washington, DC 20001 NOTICE: The project that is the subject of this report was approved by the Governing Board of the National Research Council, whose members are drawn from the councils of the National Academy of Sciences, the National Academy of Engineering, and the Institute of Medicine. The members of the committee responsible for the report were chosen for their special competences and with regard for appropriate balance. This project was supported by Contract/Grant No. DHHS-5294, Task Order #187 between the National Acad- emy of Science and the National Institutes of Health, Department of Health and Human Services. Any opinions, findings, conclusions, or recommendations expressed in this publication are those of the Committee to Study the National Needs for Biomedical, Behavioral, and Clinical Research Personnel and do not necessarily reflect the views of the organizations or agencies that provided support for the project. International Standard Book Number-13: 978-0-309-15965-4 (Book) International Standard Book Number-10: 0-309-15965-2 (Book) International Standard Book Number-13: 978-0-309-15966-1 (PDF) International Standard Book Number-10: 0-309-15966-0 (PDF) Library of Congress Control Number: 2011921184 Additional copies of this report are available from The National Academies Press, 500 Fifth Street, N.W., Lockbox 285, Washington, DC 20055; (800) 624-6242 or (202) 334-3313 (in the Washington metropolitan area); Internet, http://www.nap.edu.
    [Show full text]
  • Biomedical Sciences: 80 Credits in Major Department of Biological Sciences: Phone 320-308-2039 Or [email protected] Biomedical Sciences Major Advisors Dr
    B.S. Biomedical Sciences: 80 credits in Major Department of Biological Sciences: Phone 320-308-2039 or [email protected] Biomedical Sciences Major Advisors Dr. Marina Cetkovic 320-308-3490 [email protected] Dr. Ryan Fink 320-308-3047 [email protected] Dr. Oladele Gazal 320-308-3045 [email protected] Dr. Kristin Gulrud 320-308-3207 [email protected] Dr. JoAnn Meerschaert 320-308-2288 [email protected] Dr. Heiko Schoenfuss 320-308-3130 [email protected] Dr. Timothy Schuh 320-308-5433 [email protected] Dr. Maureen Tubbiola 320-308-4736 [email protected] F i rst S e m est er S ec o n d S e m es t er 1Biology 152 (4cr) or 151 (4cr) 1Biology 151 (4cr) or 152 (4cr) 2 Chemistry 210 (4cr) 2 Chemistry 211(4cr) 3Math 112 (3cr) 3 Statistics 239 (3cr) AND Biology 339 (1cr) Liberal Education (3cr) Liberal Education (3cr) Total semester credits=14 Total semester credits=15 Thir d S e m e s t e r F o ur t h S e m e s t e r Biology 262 (4cr) Biology 360 (4cr) Chemistry 310 (5cr) Chemistry 311 (4cr) Physics 231 (4cr) Physics 232 (4cr) Liberal Education or Biomedical Science Elective (3 or 4cr) Liberal Education or Biomedical Science Elective (6 or 7cr) Total semester credits=16 to 17 Total semester credits=14 to 15 F i fth S e m e s t e r S i xt h S em e st er Biology 362 (4cr) Biomedical Science Elective (3 or 4cr) Chemistry 480 (4cr) Biomedical Science Elective (3 or 4cr) 4Biomedical Science Elective (3 or 4cr) Biomedical Science Elective (3 or 4cr) Biomedical Science Elective
    [Show full text]
  • MSBS in Medical Sciences College of Graduate Studies Health Science Campus University of Toledo
    MSBS in Medical Sciences College of Graduate Studies Health Science Campus University of Toledo MSBS in Medical Sciences (MSBS-MS) is a one-year program designed to train students in foundational medical sciences. The 2017-2018 academic year represents a complete redesign of the former MSBS-MS program with renewed emphasis on the core-teachings of pathophysiology of disease. The program has been conceived with three primary objectives: 1. Provide clinically relevant, medical and graduate-level education to students who wish to boost their academic standing, towards a long-term goal of pursuing a career in medicine. 2. Create strong foundations for improved performance in any MD/DO-curriculum, and USMLE step 1 and step 2 exams. 3. Provide basic and clinical research opportunities to broaden student perspective and strengthen their overall portfolio. This advanced-foundational graduate program provides a unique opportunity for the graduate students to train along-side medical students (9 credits, multiple modules) and gain meaningful clinical and/or basic science research experience. The newly redesigned course also emphasizes an organ-systems based approach where clinical and graduate faculty train students in the pathophysiology of disease. This is a graduate-level course that incorporates materials taught to medical students during their first and second years, and provides foundational information for the MD curriculum. Also, pathophysiology of disease is a significant portion of the USMLE exams and its inclusion in our new MSBS-MS curriculum has the potential to increase our student-scores in step 1 and step 2. UT’s large basic and clinical-science faculty will guide students through their year-round assignment on clinical or basic research.
    [Show full text]
  • STEM Disciplines
    STEM Disciplines In order to be applicable to the many types of institutions that participate in the HERI Faculty Survey, this list is intentionally broad and comprehensive in its definition of STEM disciplines. It includes disciplines in the life sciences, physical sciences, engineering, mathematics, computer science, and the health sciences. Agriculture/Natural Resources Health Professions 0101 Agriculture and related sciences 1501 Alternative/complementary medicine/sys 0102 Natural resources and conservation 1503 Clinical/medical lab science/allied 0103 Agriculture/natural resources/related, other 1504 Dental support services/allied 1505 Dentistry Biological and Biomedical Sciences 1506 Health & medical administrative services 0501 Biochem/biophysics/molecular biology 1507 Allied health and medical assisting services 0502 Botany/plant biology 1508 Allied health diagnostic, intervention, 0503 Genetics treatment professions 0504 Microbiological sciences & immunology 1509 Medicine, including psychiatry 0505 Physiology, pathology & related sciences 1511 Nursing 0506 Zoology/animal biology 1512 Optometry 0507 Biological & biomedical sciences, other 1513 Osteopathic medicine/osteopathy 1514 Pharmacy/pharmaceutical sciences/admin Computer/Info Sciences/Support Tech 1515 Podiatric medicine/podiatry 0801 Computer/info tech administration/mgmt 1516 Public health 0802 Computer programming 1518 Veterinary medicine 0803 Computer science 1519 Health/related clinical services, other 0804 Computer software and media applications 0805 Computer systems
    [Show full text]
  • BS in Biomedical Sciences and Pharmd
    B.S./PHARM.D. BIOMEDICAL SCIENCES/DOCTOR OF PHARMACY This program intends for students to complete a B.S. in Biomedical Sciences (College of Arts and Sciences) and a Doctor of Pharmacy (USF Health College of Pharmacy) over the span of seven (7) years. Students completing this program will be well trained to perform as skilled intermediaries to effectively communicate with patients, their health providers, insurance companies, and pharmaceutical companies. Completion of this program requires students to complete the first year (36 credits) of the Pharm.D. during their senior year of their B.S. in Biomedical Sciences. This accelerated program shares 13 credits between already existing degrees/concentrations: • B.S. in Biomedical Sciences • Pharm.D. in Pharmacy Target Students and Expected Outcomes The accelerated Bachelor’s to Pharm.D. program is a collaborative effort between the College of Arts and Sciences, the Honors College, and USF Health’s College of Pharmacy (USF COP). This program is an attractive and viable career path for students in the Department of Chemistry’s degree program that results in professional training in pharmacy. Students who complete this program receive the necessary training to become advanced pharmacist clinicians that will collaborate with other health professionals. Description and Requirements For admission to the program a student must: • be admitted to the Honors College as a first year student (at least a 1300 CR+M SAT or 29 ACT and 3.8 H.S. GPA as calculated by USF); • hold US citizenship or permanent resident status. UNDERGRADUATE DEGREE REQUIREMENTS FOR THE B.S. IN BIOMEDICAL SCIENCES (BMS) All BMS students will complete FLENT and Summer Enrollment requirements as well as graduation requirements listed in the catalog.
    [Show full text]
  • Under-Represented Students in Health Care Health Professional Schools Seek Students from Racial/Ethnic Groups That Are Currently Under- Represented in the Profession
    Dec. 29 2016 Under-represented Students in Health Care Health professional schools seek students from racial/ethnic groups that are currently under- represented in the profession. Minority groups considered to have inadequate representation in the health care profession include: African Americans, American Indians, Mexican Americans, Mainland Puerto Ricans, individuals from low-income families, and first generation college students. Many professional schools offer programs to encourage and prepare minority students for study in health care. To be considered for special admissions and enrichment programs, a student should indicate minority status on their application. Socioeconomically or financially disadvantaged advisees may receive tuition assistance for exam preparation courses. Advisees must also request fee reduction or assistance from application service administrators. SUMMER PROGRAMS SELECT PRE-MEDICAL/HEALTH PROGRAMS Summer Health Professions Education Program (SHPEP) http://www.shpep.org/ Columbia University Medical Center Howard University Louisiana State University Health Science Center – New Orleans Rutgers, the State University of New Jersey University of Alabama at Birmingham University of California Los Angeles and Charles R. Drew University University of Florida University of Iowa University of Louisville University of Nebraska University of Texas Health Science Center at Houston Western University of Health Sciences Caltech Pasadena - WAVE Fellowships http://sfp.caltech.edu/programs/wavefellows Caltech’s WAVE Fellows program provides support for talented undergraduates to spend a summer working in a research laboratory on the Caltech campus. The WAVE Fellows program aims to increase the representation of underrepresented students (such as African American, Hispanic, and Native American, females who are underrepresented in their discipline, and first-generation college students) in science and engineering Ph.D.
    [Show full text]
  • Biomedical Sciences (MS) Biomedical Sciences (MS)
    Biomedical Sciences (MS) Biomedical Sciences (MS) This program is offered by the College of Arts & Sciences and is • SCML 5850 Regulatory and Qualitative Affairs for Science only available at the St. Louis home campus. Management and Leadership (3 hours) Program Description General Requirements The graduate program offers a master of science in biomedical Academic Performance sciences degree through which students can pursue multiple Students must earn a minimum cumulative GPA of 3.0 during the career opportunities (medical, dental, veterinary, pharmacology, course of study and are permitted only one course grade of C. etc). The program, built on graduate core requirements, is designed with consideration of the individual career goals of the General Requirements student in health science and research programs. Due to the 12 month, continuous cohort enrollment completion Education at the graduate level is an expansion of the knowledge of the courses will occur in the sequence prescribed by the attained from undergraduate studies. Graduate education at program for the cohort group in which enrolled; deviations from Webster University encourages the development of theoretical this sequence, or enrollment without admission to the program knowledge and critical thinking skills. The sciences are dynamic require special permission from the program director. and require a dedication to continued educational endeavors to stay abreast of current theory and changes presented through Students in the program are subject to the policies and research. procedures for graduate studies for Webster University. The curriculum spans one year of continuous, full-time Continuous Enrollment enrollment starting every Summer term with an annual Graduate students enrolled in the MS in biomedical sciences application deadline of April 15th.
    [Show full text]
  • Awareness, Attitudes and Perspectives of Direct-To-Consumer Genetic Testing in Greece: a Survey of Potential Consumers
    Journal of Human Genetics (2015) 60, 515–523 & 2015 The Japan Society of Human Genetics All rights reserved 1434-5161/15 www.nature.com/jhg ORIGINAL ARTICLE Awareness, attitudes and perspectives of direct-to-consumer genetic testing in Greece: a survey of potential consumers Vasiliki Mavroidopoulou1, Ellie Xera1 and Vasiliki Mollaki1,2 Direct-to-consumer genetic testing (DTCGT) is now offered by numerous companies. The present survey aimed to explore awareness, interest, reasons to take and refuse DTCGT, and understanding of results amongst 725 higher education students in Greece. A third of the responders were aware of DTCGT and interest was dependent on cost. More than 60% of the participants would undergo DTCGT to learn more about their health, to warn their children, so that their doctor can monitor their health and change their lifestyle. Nevertheless, they would prefer to consult their doctor first and expressed concerned about their personal data. After receiving results from a hypothetical DTC genetic test predicting higher risk for colon cancer, 59.5% of the responders thought that they could understand the results but 46.1% believed that the results have diagnostic value. In total, 83.6% of the participants would ask their doctor to explain the results and 70.4% would discuss results with their family. In conclusion, the majority of higher education students in Greece appreciate the benefits of genetic testing but with the involvement of their doctor. A physician’s participation in the process and informing the public about the true value of genetic testing, are crucial to avoid misinterpretation of DTCGT results.
    [Show full text]
  • MS in Biomedical Sciences (MBS) Program Brochure
    Boston Tufts Health Sciences Campus is located in downtown Boston and is home to several of Tufts’ health research and teaching institutions. Boston is internationally renowned for medicine and healthcare and can boast some of the world’s top medical centers, healthcare thought leaders, and life science startups. The MBS program at Tufts exposes students to organizations and individuals that will broaden their perspectives, deepen their learning experience, and bolster their professional networks. As a vibrant, cosmopolitan city with deep medical and public health roots, there is no better place than Boston to pursue a career in medicine. Tufts University School of Medicine The mission of Tufts University School of Medicine is to educate a diverse body of students and advance medical knowledge in a dynamic and collaborative environment. Tufts seeks to foster the development of dedicated clinicians, scientists, public health professionals, and educators who will have a sustained positive impact on the health of individuals, communities, and the world. Tufts University School of Medicine Office of Professional Degree Admissions 136 Harrison Avenue, Suite 142 Boston, MA 02111 medicine.tufts.edu Master of Science in Biomedical Sciences Phone: 617.636.0935 Email: [email protected] A Gateway to a Career in Medicine Tufts University School of Medicine's MS in Biomedical MBS BY THE NUMBERS CURRICULUM Sciences (MBS) Program is a rigorous, special master’s The MBS core curriculum is designed to help students excel and consists of 13 required courses, ten of which program designed for students looking to strengthen their are identical to, or based upon, Tufts University School of Medicine’s MD program courses.
    [Show full text]
  • Principles of Biomedical Science Course Number: 8708110 Course Credit: 1
    Course Title: Principles of Biomedical Science Course Number: 8708110 Course Credit: 1 Course Description: Students investigate the human body systems and various health conditions. This course is designed to provide an overview of all the courses in the Biomedical Sciences program and lay the scientific foundation for subsequent courses. Students are introduced to human physiology, medicine, research processes and bioinformatics. Key biological concepts including homeostasis, metabolism, inheritance of traits, and defense against disease are embedded in the curriculum. Engineering principles including the design process, feedback loops, and the relationship of structure to function are also incorporated. Laboratory investigations that include scientific inquiry, research, measurement, problem solving, emerging technologies, tools and equipment, as well as, experimental quality, and safety procedures will be an integral part of this course. Students will interact with materials and primary sources of data or with secondary sources of data to observe and understand the natural world. Students will develop an understanding of measurement error, and develop the skills to aggregate, interpret, and present the data and resulting conclusions. Equipment and supplies will be provided to enhance these hands-on experiences for students. A minimum of 20% of classroom time will be dedicated to laboratory experiences. CTE Standards and Benchmarks FS-M/LA NGSSS-Sci/HE SC.912.L.14.4 SC.912.N.2.1 04.0 Demonstrate an understanding of the nature of science and how to correctly use SC.912.N.2.2 appropriate scientific equipment–The student will be able to: SC.912.N.3.1 SC.912.N.3.4 04.01 Identify what is science, what clearly is not science and what can superficially LAFS.910.RI.2.4 resembles science but does not meet the criteria for science.
    [Show full text]
  • Engelberg Center for Health Care Reform
    Engelberg Center for Health Care Reform Mission The Engelberg Center is conducting a range of projects that support comprehensive health care reform. These projects and partnerships enhance the Center’s ability to implement change at all levels and bring academic and technical expertise to bear on practical solutions to state and national health care challenges. The Initiative on Value and Innovation in Health Care is the Center’s cornerstone project. The Initiative works to develop data-driven, practical health reforms that promote broad access to high-quality, affordable care with a focus on continuous health care improvement. The projects within the Initiative focus on changes in policy and practice to improve health care through innovation in biomedical science and clinical practice, reforms in health care delivery and realignment of payments and incentives to promote better evidence, better quality and better health care. Driven by staff with expertise in policy, biomedical science, and clinical practice, projects within the Initiative involve new ideas, analyses, and practical strategies for implementing them. Many of the projects are supported by broad-based collaborations with a wide range of external stakeholders. Putting this all together results in feasible approaches for driving real health care reform to achieve higher quality health care at a lower cost. (Click to Initiative page) Initiative on Value and Innovation in Health Care The Initiative on Value and Innovation in Health Care works to develop data-driven, practical solutions that promote broad access to high-quality, affordable care that keeps getting better. Simply expanding health insurance coverage to promote access, or trying to lower costs by cutting prices or limiting covered services, will not be enough to achieve health care that does much more to improve health, that is affordable, and that keeps getting better by incorporating new clinical breakthroughs and better evidence.
    [Show full text]
  • Quality CARE, to THE
    DURING HER RESIDENCY IN INTERNAL MEDICINE AT UB, AMY MCDONALD, MD ’01, FOUND THAT SHE WASN’T INTIMIDATED BY THE PROSPECT OF DISCUSSING DEATH AND DYING WITH TERMINALLY ILL PATIENTS. ON THE CONTRARY, SPEAKING CANDIDLY AND COMPASSIONATELY ABOUT END-OF-LIFE ISSUES, WHILE OFFERING HER PATIENTS AN OPPORTUNITY TO OPEN UP ABOUT THEIR FEARS AND WISHES, CAME NATURALLY TO HER. Or, at least more naturally than her peers. Once Palliative Medicine within the Department of QUAlITy CARE, they learned that she was comfortable broaching Internal Medicine. such a difficult bedside subject, McDonald’s phone According to division director Jack Freer, MD To THE EnD began to ring. ’75, organizing palliative medicine into a division UB eSTaBLiSHeS diViSiOn OF PaLLiaTiVe MediCine “My colleagues would call and ask me, ‘Can you brings recognition to both a subspecialty that is By Nicole Peradotto talk to my patient about this, too?’” she recalls. coming into its own and the faculty charged with Five years later, McDonald has parlayed her teaching the next generation of physicians how to sought-after communication skills into a fulfill- alleviate suffering and promote quality of life for ing career in palliative medicine. An assistant patients nearing the end of life. professor of medicine at UB, she runs the 20-bed palliative care unit at the Buffalo Veterans Affairs Medical Center and is director of UB’s palliative medicine fellowship, one of 55 accredited pro- grams in the country. “People think that working in the field of hospice is depressing. My answer is, ‘Not at all,’” McDonald says. “In the same way that it’s rewarding for an obstetrician to bring a life into the world, it can be rewarding to help people go through the dying process.
    [Show full text]